LXRX (Lexicon Corp) Wutah bathi ing taun lumaku

LXRX (Lexicon Corp) - tandha merek perusahaan

Lexicon Pharmaceuticals (LXRX) relies on external contractors for drug manufacturing, ensuring quality through strict regulations. Management is striving for profitability while overcoming insurance coverage challenges. The annual EPS volatility confirms these processes, where the current status is -13.60. This underscores the company's status as a creator of unique molecules for metabolism regulation, opening new horizons in the treatment of diabetes.

LXRX: Wutah bathi saben saham ing taun lumaku Lexicon Pharmaceuticals 04.07.2022 - 15.11.2026

Rincian metrik keuangan lan pasar Lexicon Pharmaceuticals Inc (LXRX)

- rega saham lan prakiraan rega para ahli:
Rega Lexicon Pharma|LXRX - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Kapitalisasi pasar Lexicon Pharmaceuticals|LXRX - Nilai Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Siji Saham Lexicon Pharmaceuticals|LXRX - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku lexpharma.com|LXRX - Aset Agregat Perusahaan
- indikator beban utang lan likuiditas:
Utang marang Ekuitas Lexicon Pharmaceuticals|LXRX - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Lexicon Pharmaceuticals Inc|LXRX - Utang perusahaan|Utang-utang marang aset resik Lexicon Pharmaceuticals, Inc.|LXRX - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Lexicon Pharmaceuticals|Likuiditas cepet lexpharma.com
- informasi bathi lan kelipatan valuasi:
LXRX - Bathi resik|Bathi resik sing dikarepake Lexicon Pharmaceuticals|LXRX - Koefisien rega marang bathi|Rasio rega marang bathi mangsa ngarep Lexicon Pharmaceuticals|LXRX - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Lexicon Pharmaceuticals|LXRX - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Lexicon Pharmaceuticals|LXRX - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan lexpharma.com|LXRX - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Lexicon Pharmaceuticals
- data pendapatan lan penerimaan dodolan:
LXRX - Dodolan perusahaan|Pendapatan mangsa ngarep perusahaan Lexicon Corp|LXRX - Rasio rega marang pendapatan|Rega mangsa ngarep marang pendapatan Lexicon Pharmaceuticals|LXRX - Wutah dodolan YoY (TTM)
Analisis dhasar perusahaan:LXRX - Lexicon Corp
Produk dadi Lexicon Pharmaceuticals, Inc.

The diversification of the drug portfolio for the therapy of diabetes and cardiovascular pathologies directly determines the monetization efficiency of Lexicon Pharmaceuticals (LXRX) R&D assets. An analysis of the EPS trajectory compared to last year allows for an assessment of the net income growth rate per share, which serves as an indicator of capital density and reflects a shift in market consensus regarding the fundamental value of the business over the long term.

Pesaing utama

ASND: Wutah bathi resik saben siji saham kanggo taun lumaku|MDGL (Madrigal Corp) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku Corcept Therapeutics|Wutah bathi ing taun lumaku RYTM|Wutah bathi saben saham ing taun lumaku AKRO (Akero Therapeutics, Inc.)|Wutah bathi saben saham ing taun lumaku metsera.com MTSR|MoonLake Corp (MLTX) - Kacepetan wutah bathi saben saham ing taun lumaku|CRNX - Wutah bathi saben saham ing taun lumaku|NAMS: Wutah bathi saben saham ing taun lumaku|SLNO: Wutah bathi ing taun lumaku|FOLD - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku 89bio Pharma|Agios Corp (AGIO) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku structuretx.com (GPCR)|Wutah bathi resik saben saham ing taun iki mimedx.com MDXG|Wutah bathi saben saham ing taun lumaku Rezolute RZLT|MBX Bio - Wutah bathi saben saham ing taun lumaku|ALT: Wutah bathi resik saben saham ing taun iki|AARD - Wutah bathi ing taun lumaku|SGMT: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku BioAge Labs, Inc. (BIOA)|Wutah bathi saben saham ing taun lumaku Biomea Fusion Inc|Wutah bathi saben saham ing taun iki QNCX (Quince Therapeutics)|Wutah bathi resik saben saham ing taun iki GUTS (Fractyl Health)|Wutah bathi resik saben siji saham kanggo taun lumaku VTVT|Agape ATP Corporation - Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku PLUR|Synlogic Inc. - Wutah bathi ing taun lumaku|LPCN (Lipocine) - Wutah bathi saben saham ing taun iki|MTNB (Matinas BioPharma Holdings Inc.) - Wutah bathi resik saben saham ing taun iki|SPRB (Spruce Biosciences, Inc.) - Wutah bathi saben saham ing taun lumaku|GLTO (galecto.com) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki carmellrx.com (CTCX)|Wutah bathi saben saham ing taun lumaku Lumos Pharma (LUMO)|ONVO (Organovo Holdings) - Tambahing bathi saben saham ing taun lumaku|radiuspharm.com - Wutah bathi resik saben saham ing taun iki